文献速递生殖医学产科

既往剖宫产对体外受精结局的影响:基于注册数据库的队列研究

The impact of a previous cesarean delivery on in vitro fertilization outcomes: a registry-based cohort study.
PubMed 文献 · Am J Obstet Gynecol · 2026-02-19

该研究基于加拿大安大略省注册数据库,纳入2013年至2020年间既往有分娩史且随后接受胚胎移植的7460例患者,比较既往剖宫产与阴道分娩者首次胚胎移植后的活产率。结果显示剖宫产组活产率显著降低(aRR 0.84,95%CI 0.80-0.90),其他妊娠结局亦较低,但为关联性结论。

要点

  • 既往剖宫产与首次胚胎移植后活产率降低相关(aRR 0.84,95%CI 0.80-0.90)。
  • 剖宫产组hCG阳性率、着床率、临床妊娠率、持续妊娠率及良好围产结局活产率均较低。
  • 该研究为回顾性注册队列,不能排除残余混杂,结果应解读为关联而非因果。

核心结论

  • 与既往阴道分娩相比,既往剖宫产与首次后续胚胎移植后活产率及其他生育相关妊娠结局降低相关。

主要发现

  • 剖宫产组活产率显著低于阴道分娩组(调整风险比0.84,95%CI 0.80-0.90;风险差-4.6/100,95%CI -6.8至-2.4)。
  • 剖宫产组hCG阳性率较低(调整风险比0.92,95%CI 0.88-0.96)。
  • 剖宫产组着床率较低(调整风险比0.91,95%CI 0.86-0.96)。
  • 剖宫产组临床妊娠率较低(调整风险比0.90,95%CI 0.85-0.95)。
  • 剖宫产组持续妊娠率较低(调整风险比0.87,95%CI 0.82-0.92),良好围产结局活产率亦较低(调整风险比0.82,95%CI 0.76-0.88)。

临床怎么用

  • 对有剖宫产史拟行胚胎移植的患者,应告知其活产率可能低于阴道分娩史者。
  • 咨询时可参考调整风险比0.84及风险差-4.6/100等数值,但需说明为关联性证据。

局限性

  • 回顾性注册研究设计,不能排除残余混杂,结果应解读为关联而非因果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cesarean delivery rates have climbed over the past few decades. We sought to evaluate whether a previous cesarean delivery is associated with reduced live birth rates following a subsequent embryo transfer when compared with patients with a history of vaginal delivery. OBJECTIVE: This study aimed to evaluate the impact of a previous cesarean delivery by reporting the live birth rate following the first embryo transfer and comparing it with the rates among patients with a previous vaginal delivery. STUDY DESIGN: We performed a retrospective, registry-based cohort study of all patients in Ontario, Canada, with a previous delivery, either vaginal or cesarean delivery, who subsequently had an embryo transfer between January 1, 2013, and December 31, 2020. A total of 7460 patients were included of which 4587 patients were in the vaginal delivery group and 2873 patients were in the cesarean delivery group. Data from the provincial birth register, Better Outcomes Registry & Network Ontario, and from the fertility registry, Canadian Assisted Reproductive Technology Register Plus were used for this study. A modified Poisson regression model was used to estimate the relative risk with 95% confidence intervals. Models were adjusted for age at oocyte retrieval, age at embryo transfer, number of previous deliveries, number of embryos transferred, type of embryo transfer (fresh vs frozen-thawed), and embryo stage at transfer. Crude risk differences with 95% confidence intervals were calculated. RESULTS: Patients with a previous cesarean delivery had a statistically significant lower live birth rate (adjusted risk ratio, 0.84; 95% confidence interval, 0.80-0.90; risk difference, -4.6 per 100; 95% confidence interval, -6.8 to -2.4), positive human chorionic gonadotropin rate (adjusted risk ratio, 0.92; 95% confidence interval, 0.88-0.96), implantation rate (adjusted risk ratio, 0.91; 95% confidence interval, 0.86-0.96), clinical pregnancy rate (adjusted risk ratio, 0.90; 95% confidence interval, 0.85-0.95), ongoing pregnancy rate (adjusted risk ratio, 0.87; 95% confidence interval, 0.82-0.92), and live birth rate with good perinatal outcome (adjusted risk ratio, 0.82; 95% confidence interval, 0.76-0.88) when compared with patients with a previous vaginal delivery. CONCLUSION: A previous cesarean delivery was associated with lower live birth rates and other fertility-related pregnancy outcomes after the first subsequent embryo transfer when compared with a previous vaginal delivery. Because residual confounding cannot be excluded in this retrospective, registry-based study, these findings should be interpreted as associations. The results of this study emphasize the importance of further research to investigate possible etiologies that underlie this association.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Létourneau I, Walker M, Gale J, et al. The impact of a previous cesarean delivery on in vitro fertilization outcomes: a registry-based cohort study. Am J Obstet Gynecol. 2026. PMID: 41722753. doi:10.1016/j.ajog.2026.02.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。